January 18, 2021 — According to a new national survey released Jan. 13 by the Society for Cardiovascular Angiography and Interventions (SCAI), nearly 40 percent of Americans still do not feel safe going to the doctor's office while coronavirus (COVID-19) is still a risk.

January 13, 2021 — FineHeart, a preclinical-stage medical device company developing a novel left ventricular assist device (LVAD), successfully completed a seven-day study of its Transcutaneous Energy Transfer (TET) System for recharging the ICOMS implantable battery without any cords or drivelines through the skin. 

January 11, 2021 — In a letter published in the December issue of the American Heart Association (AHA) medical journal Circulation a group of researchers at Vanderbilt University Medical Center (VUMC) dispute the most recent findings of the incidence of myocarditis in athletes with a history of

January 12, 2021 — The American Heart Association (AHA) and the American Medical Society for Sports Medicine (AMSSM) are joining forces to accelerate a critical new research initiative studying cardiac conditions in athletes, in part to speed new insights into the impact of COVID-19 (SARS-CoV-2) to the cardiovascular system of college athletes and safety of return to play after diagnosis.

January 11, 2021 — Medtronic has received a new expanded indication from Health Canada for its Evolut Transcatheter Aortic Valve Implantation (TAVI) system. Medtronic's TAVI platform is currently the only system licensed for both bicuspid aortic valves (intermediate or greater risk), as well as all surgical risk categories in Canada.

January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found evidence that Apple's new iPhone 12 might cause implantable cardioverter defibrillators (ICDs) to become inoperable if placed are near the implanted de

While the FDA said the risk that SARS-CoV-2 virus mutations will only have a minor impact on testing accuracy is low, the agency singled out three tests are they had a higher concern. FDA warns PCR tests may be innaccurate with new UK virus varient.

January 8, 2021 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers that it is monitoring the potential impact of COVID (SARS-CoV-2) viral mutations, including the emerging variant from the United Kingdom and its potential to produce false negative results on FDA authorized SARS-CoV-2 molecular tests.

Despite the alert issued today, the FDA believes the risk that these mutations will impact overall testing accuracy is low.

January 8, 2021 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Inari Medical Inc. FlowTriever system for the treatment of clot in transit (CIT) in the right atrium.

FlowTriever is the first thrombectomy system not requiring a cardiopulmonary bypass circuit to be FDA cleared for blood clots in the right atrium. 

January 8, 2020 – RSIP Vision has launched a new artificial intelligence (AI) ultrasound module that enables fast and accurate point-of-care heart evaluations. This includes onsite diagnostic from the parasternal long axis (PLAX) view. This new vendor-neutral technology will be available to third-party ultrasound manufacturers and medical devices vendors.

January 6, 2020 — A new Weill Cornell Medicine found the risk of dying seven years after coronary artery bypass graft (CABG) surgery was significantly lower in men receiving multiple bypass grafts rather than single grafts. The study also looked at CABG in women and there was no apparent difference between single or multiple vessel bypass procedures, but overall women had a higher mortality rate. The study published online Dec.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now